A: Rybelsus provides effective glycemic control as an oral GLP-1 receptor agonist while eliminating the need for injections
1,152 adults with obesity/overweight and type 2 diabetes, randomized to retatrutide 4mg, 9mg, 12mg, or placebo over 80 weeks
When itching does occur during tirzepatide therapy, it is typically mild to moderate and often resolves within the first few weeks as the body adjusts to the medication
Studies have shown that Ozempic, particularly at higher doses specifically approved for weight management (under the brand Wegovy), often delivers superior results in reducing body weight, BMI, and waist circumference
But for day-to-day hydration needs, water is usually sufficient unless you have specific electrolyte deficiencies